Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: without difficulty (163), simply (108)

Radioactive seed implants for prostate cancer low dose rate brachytherapy - patient information

Description: Radioactive seed implants (low dose rate brachytherapy) are a way of using radiotherapy to treat prostate cancer that is contained within
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Radioactive-seed-implants-for-prostate-cancer-low-dose-rate-brachytherapy-954-PIL.pdf

Finance and Performance Reports 2022-23 Month 2 May 2022

Description: Report to the Trust Board of Directors Title: Agenda item: Sponsor: Author: Date: Purpose Issue to be addressed: Finance Repo
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2022-Trust-documents/Finance-and-Performance-Reports-2022-23-Month-2-May-2022.pdf

Bevacizumab (15mgkg), Carboplatin and Gemcitabine (1,8)

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER BEVACIZUMAB (15)-CARBOPLATIN (AUC4)-GEMCITABINE (day 1, 8) Regimen • Ovary-Bevacizumab (15)-Carboplatin (AUC4)-Gemcitabine (1, 8) Indication • Recurrent platinum sensitive ovari
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Bevacizumab15mgkgCarboplatinAUC4Gemcitabineday18.pdf

Carboplatin (AUC5) -Pegylated Liposomal Doxorubicin Retreat

Description: Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC5) – PEGYLATED LIPOSOMAL DOXORUBICIN (Caelyx) Retreat Please note this p
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Carboplatin-AUC5-Pegylated-Liposomal-Doxorubicin-Retreat-Caelyx.pdf

Going home after your stay at the major trauma centre - patient information

Description: This factsheet gives you useful information about returning home after your stay at the trauma centre.
Url: /Media/UHS-website-2019/Patientinformation/Major-Trauma-Centre/Going-home-after-your-stay-at-the-major-trauma-centre-3124-PIL.pdf

Transient ischemic attack (TIA) - patient information

Description: Transient ischemic attack (TIA) Information for patients You have been given this booklet because you have been referred to the TIA clinic. This means that you have had a
Url: /Media/UHS-website-2019/Patientinformation/Brain-and-spine/Transient-ischemic-attack-TIA-685-PIL.pdf

Enhanced recovery after anti-reflux surgery - patient information

Description: This factsheet is designed to help increase your understanding of the enhanced recovery programme, and to enable you and your family
Url: /Media/UHS-website-2019/Patientinformation/Surgery/Enhanced-recovery-after-anti-reflux-surgery-3319-PIL.pdf

Breathing pattern disorders - patient information

Description: Breathing pattern disorders are patterns of overbreathing, where the depth and rate of breath are in excess of the body's needs
Url: /Media/UHS-website-2019/Patientinformation/Respiratory/Breathing-pattern-disorders-patient-information.pdf

Rituximab-Gemcitabine-Oxaliplatin (R-GemOx)

Description: Chemotherapy Protocol LYMPHOMA RITUXIMAB-GEMCITABINE-OXALIPLATIN (R-GemOx) Regimen • Lymphoma – Rituximab-Gemcitabine-Oxaliplatin (R-GemOx) Indication • Salvage regimen for relapsed/refractory lymphoma Toxicity Dr
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Rituximab-Gemcitabine-Oxaliplatin-R-GemOx.pdf

PV-CHP Cyclophosphamide-doxorubicin-polatuzumab vedotin -prednisolone

Description: Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-DOXORUBICIN-POLATUZUMAB VEDOTIN-PREDNISOLONE- RITUXIMAB Regimen • Lymphoma – Cyclophosphamide-doxo
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/PV-CHP-Cyclophosphamide-doxorubicin-polatuzumab-vedotin-prednisolone.pdf

301 to 310 of 367

Previous … 29 30 31 32 33 … Next